In the present study, we find increased Rab10 phosphorylation in iPD patients and affected G2019S-LRRK2 carriers only, whereas levels in healthy carriers and A53T-SNCA PD patients are not changed from healthy controls. Here, LRRK2 is linked to Parkinson disease.